^
Association details:
| Biomarker: | CCND1 expression |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | Venclexta (venetoclax) (Bcl2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
SYSTEMATIC IDENTIFICATION OF PHARMACOGENOMICS INTERACTIONS MODULATING DRUG RESPONSES IN MULTIPLE MYELOMA
Published date:
05/17/2018
Excerpt:
100 bone marrow (BM) aspirates were collected from 32 newly diagnosed and 51 relapsed myeloma patients...CCND1 and BMI1 expression correlated with sensitivity to BCL2 inhibitor venetoclax.
